CDC's John Jernigan Discusses Landmark REDUCE MRSA Trial

Today, on CDC's Safe Healthcare Blog, John Jernigan, MD, director of CDCs Office of Prevention Research and Evaluation and head of CDCs Prevention Epicenters Program, provides insight into how a collaboration between public health, academia, and a health system took a novel idea from a hypothesis to 74,000 patients.

Carried out by a multidisciplinary team from the University of California Irvine; Harvard Pilgrim Health Care Institute; Rush University; Stroger Hospital of Cook County; Washington University in St. Louis; Hospital Corporation of America and the CDC. The trial was federally funded by and conducted through research programs at the Agency for Healthcare Research and Quality (AHRQ) and the CDCs Prevention Epicenters program.

Read the story behind the research at: